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Neural stem cells/progenitor cellsThe majority of glutamate released during neurotransmission is uptaken into astrocytes through the glial
glutamate transporter GLT-1, by which extracellular glutamate is inactivated. In this study, we deter-
mined whether GLT-1 mediated the astrocyte regulation of the cell fate of neural stem/progenitor cells
(NSCs) by glutamate reuptake. The astrocytes stimulated neuronal lineage selection but inhibited glial
lineage cells. However, all these effects were reversed after siRNA-targeting GLT-1 was delivered into
astrocytes by lentiviral vectors. NSC and astrocyte co-culture also increased the synaptophysin protein
levels of NSC-derived new neurons through GLT-1. Glutamate was found to be present in the superna-
tants of the co-culture and astrocytes under different medium conditions, which may be attributed to
the slower rate of clearance of the released glutamate. Dysfunctional glutamate reuptake may be the
major consequence of GLT-1 functional silence in astrocytes. These results indicated that astrocytes reg-
ulated NSCs in reactive astrogliosis, neuronal generation, and synaptic function through GLT-1.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Neurogenesis occurs in the two germinal zones of the adult
mammalian central nervous system (CNS), including the subgran-
ular zone of the hippocampus (Taupin and Gage, 2002). Neural
stem/progenitor cells (NSCs) isolated from this region retain the
potential of self-renewal and multi-lineage differentiation. These
NSCs also generate new granular layer neurons in the dentate
gyrus throughout a lifespan (Abrous et al., 2005). This property
contributes to functional plasticity under both physiological and
pathological conditions. For example, ischemia-stimulated com-
pensatory neurogenesis can enable rehabilitation after injury and
facilitate cognitive recovery (Raber et al., 2004). We have previ-
ously observed depressive behaviors in post-stroke animals in
which ischemia-stimulated neurogenesis has been attenuated
(Wang et al., 2008), which revealed the potential etiology of
post-stroke depression.
In addition to the neurogenic capacity of NSCs, they can divide
and differentiate into glial lineages (Palmer et al., 1997, 2000; Stei-
ner et al., 2004). Astrocytes are fundamental to the onset, progres-
sion, and outcome of neuropathological processes. These cells limit
damage and promote the revascularization of surrounding tissue
through reactive astrogliosis (Giaume et al., 2007; Heneka et al.,2010; Nedergaard et al., 2010). However, the majority of NSCs dif-
ferentiate into astrocytes instead of neurons in damaged lesions,
thereby limiting the use of NSCs as potential therapeutic agents
for brain injury. We have previously found that chronic unpredict-
ed mild stress can alter ischemia-induced neurogenic fate by
increasing the glial lineage differentiation of NSCs (Wang et al.,
2008). Therefore, controlling the direction of NSC differentiation
is a major challenge in treating CNS diseases (Emsley et al., 2005).
Faijerson et al. (2006) modeled astrogliosis in vitro using
mechanical lesions of primary astrocytes. They found that lesioned
astrocytes stimulate the astrocytic differentiation of NSCs without
affecting neuronal or oligodendrocytic differentiation. Moreover,
co-culturing NSCs with lesioned astrocytes reveals that several of
these NSC-derived astrocytes participate in glial scar formation
in vitro. Thus, astrocytes likely affect the cell behavior and fate of
NSCs after brain injury. However, the molecular mechanisms
underlying astrocyte-induced NSC activity especially during dis-
eases remain elusive.
Astrocytes, which are components of the tripartite synapse,
modulate neurotransmission and control the extracellular level of
neurotransmitters (Araque et al., 1999; Danbolt, 2001; Grosche
et al., 1999; Halassa and Haydon, 2010; Perea et al., 2009; Wil-
helmsson et al., 2006). Therefore, astrocytes are essential to the
glutamate–glutamine cycle, which is fundamental for the synaptic
plasticity associated with cognitive processes (Kvamme, 1998;
McKenna, 2007). Astrocytic glutamate uptake prevents glutamate
excitotoxicity (Danbolt, 2001). However, the disturbance of
Y. Guo et al. / Neurochemistry International 63 (2013) 498–506 499astrocytic-based glutamate homeostasis may lead to neurotrans-
mitter imbalance, neuronal malfunction, impaired cognition, and
death (Choi, 1992; Walton and Dodd, 2007). The majority of gluta-
mate released during neurotransmission is uptaken into astrocytes
by the mediation of a family of high-afﬁnity glial glutamate trans-
porters including GLAST/EAAT1 and GLT-1/EAAT2, which is the
only mechanism by which extracellular glutamate is inactivated.
Several studies have documented that GLT-1 is critical to the main-
tenance of extracellular glutamate below neurotoxic levels (Kanai
et al., 1997; Rothstein et al., 1996; Rothstein et al., 1994). Dimin-
ished expression of GLT-1 contributes to neurodegenerative disor-
ders (Choi, 1988), including Alzheimer’s disease (Li et al., 1997;
Masliah et al., 2000).
Studies have indicated that dysfunctional glutamate reuptake
promotes neuronal death after brain injury (Rao et al., 2000; Torp
et al., 1995). However, the functional signiﬁcance of glutamate
transporter subtypes in inducing the cell fate of NSCs has not yet
been reported. In the present work, a cell co-culture of astrocytes
and NSC medium was produced using Transwell dishes. We deter-
mined whether GLT-1 modulated the astrocyte regulation of the
cell fate, reactive astrogliosis, neuronal differentiation, and synap-
tic formation of NSCs by delivering the siRNA-targeting GLT-1 into
astrocytes using lentiviral vectors.2. Materials and methods
2.1. Preparation of a lentiviral vector expressing short hairpin RNA
(shRNA) against GLT-1
Vectors were constructed using standard cloning procedures.
Oligonucleotides encoding both strands of the targeting sequence
were annealed and ligated into the MluI/ClaI site in pLVTHM vec-
tor. The nucleotide sequence of shRNAs targeting rat GLT-1 gene
was as follows: Rat-GLT-1-sh: 50-GAGCTACCTGTTTCGGAAT-30.
Their scrambled sequence used as control was 50-
TTCTCCGAACGTGTCACGT-30. About 1 lL of annealed oligonucleo-
tides, 2 pmol of MluI/ClaI digested vector pLVTHM, 1 lL of 10
ligation buffer, 1 lL of T4 DNA ligase (TaKaRa), and ddH2O were
mixed together. About lL of the ligation mixture was incubated
at 4 C overnight. Approximately 5 lL of ligation products was
transfected into competent Escherichia coli DH5a (TaKaRa). The
vector including the shRNA was conﬁrmed by sequencing (Supple-
mentary Figure 1). About 10 lg of pLVTHM or pLVTHM/shRNA and
10 lg of packing mix pRsv-REV, pMDlg-pRRE, and pMD2.G (Invit-
rogen) were mixed together and then transfected into 293T cells
according to the manual of Lipofectamine 2000 (Invitrogen). The
transfected medium was replaced with fresh medium 6 h after
transfection. Culture supernatants were collected 48 h after trans-
fection and referred to as Lv-shGLT-1 or Lv-NC. The transfecting
supernatants were puriﬁed by ultracentrifugation. Virus titers
were calculated at 72 h after virus infection in 293T cells by count-
ing the number of green ﬂuorescent proteins expressing foci di-
vided by the dilution factor.Table 1
The primers for real-time PCR.
Gene Primers
GLT-1-F 50 CCTGTTTCGGAATGCCTTTGTGCT 30
GLT-1-R 50 TATACGGTCGGAGGGCAAATCCAA 30
b-actin-F 50 TTGCTGACAGGATGCAGAAGGAGA 30
b-actin-R 50 ACTCCTGCTTGCTGATCCACATCT 302.2. Cell culture and transfection
Following the method of McManus and Trombetta (1995), rat
hippocampal astrocytes from 1- to 3-day-old Sprague–Dawley rat
pups were cultivated in Dulbecco’s modiﬁed Eagle’s medium
(DMEM)/Ham’s F12 nutrient media supplemented with 10% heat-
inactivated fetal bovine serum (FBS) and 0.1 mg/mL gentamycin.
The astrocytes were puriﬁed using differential speed, shaken at
room temperature, and then washed for 10 min with DMEM to re-
move microglia and oligodendrocytes. The astroglial lineage of the
resulting cells was conﬁrmed by the presence of glial ﬁbrillaryacidic protein (GFAP). Astrocytes were cultured at a density of
5  104 cells/mL in a culture bottle to synchronize for cell transfec-
tion. For cell infection, astrocytes were incubated with Lv-shGLT-1
or Lv-NC for 120 h, and the mediumwas replaced 24 h after adding
the lentiviruses (MOI = 10). Stably transfected clones were selected
using puromycin dihydrochloride (Sigma–Aldrich) selection.
The silenced gene and protein expression of GLT-1 were con-
ﬁrmed by real-time PCR and Western blot analysis. Total RNA
was isolated from cultured cells using Trizol (Ambion). Total RNA
(1 lg) was used as a template for RT with a High-Capacity cDNA
RT Kit (Applied Biosystems). Real-time RT-PCR was performed by
monitoring the increase in ﬂuorescence of SYBR Green dye using
the Rotor-Gene 3000 Real-time PCR apparatus (Corbett Research)
according to the manufacturer’s instructions. All PCR primers were
designed by Primer Express Software V2.0 (Table 1). All measure-
ments were conducted in triplicate. For immunoblot analysis, cells
were collected and homogenized in ice-cold lysis buffer [contain-
ing 20 mmol/L Tris (pH 7.5), 150 mmol/L NaCl, 1 mmol/L EDTA,
1 mmol/L EGTA, 1% Triton X-100, 2.5 mmol/L Na-pyrophosphate,
1 mmol/L b-glycerophosphate, 1 mmol/L Na3VO4, 1 g/mL leupep-
tin, and 1 mmol/L PMSF]. The cells were then centrifuged at
16,000 rpm for 15 min. Protein samples were electrophoresed on
10% Bis–Tris gels (Invitrogen) and transferred onto polyvinylidene
ﬂuoride membranes according to the manufacturer’s instructions
(Invitrogen). Immunoblot analyses were carried out with the fol-
lowing antibodies: anti-GLT-1 (1:500, Santa Cruz) and anti-b-actin
(1:2000, Santa Cruz). Protein expression level was quantiﬁed by
densitometry (TotalLab, version 1.1, UK) for each blot. The density
ratio for the bands was calculated. All data were expressed relative
to control as follows: relative density (%) = density (study groups)/
density (control group)  100.2.3. Preparation and co-culture of NSCs with astrocytes using
Transwell dishes
NSCs were prepared as described by Wang et al. (2009) with
minor modiﬁcations. In a typical procedure, an ordinal pregnant
Sprague–Dawley rat was intraperitoneally injected with 0.4% so-
dium phenobarbital and decapitated at 13.5 gestational days. The
brains were removed from the embryo and placed in DMEM/F12
(1:1) medium (Gibco) containing 20 mg/mL basic ﬁbroblast growth
factor (Gibco), 20 mg/mL epidermal growth factor (EGF, Gibco),
10 mg/mL N2 (Gibco), and 20 mg/mL B27 supplement (Gibco). Pri-
mary proliferative neurospheres were formed and passaged by
mechanical dissociation. In a Transwell dish, NSCs were plated in
poly-l-lysine pretreated six-well dishes (Nunc), and protoplasmic
astrocytes were cultured in the insert (Millipore, MA, USA). The
pore size of the Transwell dish was 0.1 lm. Monoclonal NSCs were
subcultured at a density of 5  104 cells/mL and divided as follows:
group A, NSCs without astrocytes; group B (independent of the se-
quence of the hairpin structure of the virus carrier; provided by
Shanghai Sangon Biotech Co., Ltd), NSCs co-cultured with control
vector infected astrocytes; and group C, NSCs co-cultured with len-
tiviral vector-based GLT-1 RNAi-transfected astrocytes. Co-cul-
tured cells were maintained in NB + 2% B27 medium. Half of the
medium was changed every 3 days. After 7 days of co-culture, we
Table 2
Expression of GLT-1 mRNA in groups, as determined by the 2DDCt relative quantiﬁcation algorithm.
Group Ct b-actin Ct GLT-1 DCt DDCt 2DDCt
Vector control (Control) 8.96 ± 3.51 19.61 ± 0.32 10.65 ± 0.52 0.05 ± 0.52 1.00 ± 0.36
Glut1 siRNA astrocytes (Sample) 9.10 ± 0.35 21.28 ± 0.24 12.18 ± 0.55 1.58 ± 0.54 0.36 ± 0.13#
Expression of GLT-1 mRNA analysed by the 2DDCt relative quantiﬁcation algorithm.
DCt = CtGLT-1Ctreference. DDCt = (Ct GLT-1Ct reference)control(Ct GLT-1Ct reference)sample.
The N-fold differential expression in a speciﬁc gene of the sample related to the DDCt control counterpart was determined and expressed by 2DDCt. Values are means ± S.D.
N = 3 for each group.
# Indicates P < 0.01, Glut1 siRNA astrocytes (Sample) vs. Vector control (Control).
Fig. 1. Knock-down efﬁciency of the shRNAs. Immunoblot analysis indicates that
shRNAs delivered by lentiviral vectors silenced GLT-1 expression in astrocytes.
#indicates P < 0.01, GLT-1 siRNA astrocytes vs. vector control.
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differentiation conditions. The abovementioned serum-free mito-
genic medium was used for proliferation and differentiation stud-
ies. The NSCs that adhered onto glass coverslips precoated with
poly-l-ornithine/laminin were induced to differentiate using
DMEM/F12 (1:1) medium containing 10% FBS for 3 days to 7 days.
2.4. Evaluation of cell growth
Cell viability was assayed by the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide absorbance and cell count assay.
The absorbance at 570 nm was measured in solubilized cells using
spectrophotometry (Hitachi). The cell growth rate was expressed
as a percentage of values obtained in the vehicle control. In another
set of experiments, primary spheres were collected, passaged by
mechanically dissociating neurospheres in 0.2 mL of serum-free
media, and then plated at 500 cells/well in uncoated 96-well
plates. The number of spheres was counted after 3 and 7 days
in vitro. Up to 6–8 wells per condition tested were counted.
2.5. Evaluation of differentiation and synaptic density
NSCs were Transwell co-cultured with astrocytes onto poly-l-
ornithine/laminin-coated coverslips for 7 days. 5-Bromodeoxyuri-
dine (BrdU) was dissolved in phosphate-buffered saline (PBS) and
added to the culture medium at a ﬁnal concentration of 10 lM
for 15 min at 37 C. The NSCs were washed twice and further incu-
bated at 37 C for 10 h, ﬁxed with 4% paraformaldehyde in PBS for
10 min, permeabilized in PBS containing 0.1% Triton X-100 for
30 min, and washed. The ﬁxed cells were incubated with
anti-microtubule-associated protein 2 (MAP2; 1:500, Invitrogen)
followed by incubation with FITC-conjugated anti-rabbit IgG anti-
body (1:1000, Vector) or anti- BrdU antibody (1:200, Chemicon)
followed by rhodamine-conjugated goat anti-mouse immunoglob-
ulin (IgG) antibody (Vector, 1:500 dilution). Nuclear staining was
performed by incubation with FITC-conjugated anti-rabbit IgG
antibody (1:1000, Vector), and NSCs were observed using a confo-
cal laser scanning microscope (Zeiss LSM510, Carl Zeiss) equipped
with a 40 objective at excitation/emission wavelengths of 535/
565 nm (Rhodamine, red) and 470/505 nm (FITC, green).
The examine was repeated three times, and 8–10 coverslips
(each group) were examined each time, approximately 100–200
cells were randomly counted per coverslip in a blind manner. Neu-
ronal and glial differentiations were expressed as the percentages
of MAP2+ and GFAP+ cells quantiﬁed by normalizing total MAP2
or GFAP cells to the total number of cells labeled with BrdU
(approximately 100–200 cells were randomly counted per cover-
slip in a blind manner; n = 3 dissections).
The percentage of synaptophysin positive cells was expressed
as a percentage of the number of synaptophysin+/MAP2+ cells.
The ﬁxed cells were incubated with anti-MAP2 (1:500) and anti-
synaptophysin antibodies (1:500, Abcam) overnight at 4 C, visual-
ized with rhodamine-conjugated goat anti-mouse IgG antibody
(1:1000, Vector) and FITC-conjugated anti-rabbit IgG antibody(1:500, Vector) for 1 h at room temperature. The cells were then
counterstained with 300 nM 4,6-diamidino-2-phenylindole dihy-
drochloride (DAPI; Sigma) for 3 min. The labeled cells were
scanned using a confocal laser scanning microscope.
The synaptophysin protein levels were investigated using Wes-
tern immunoblot analysis. Cells were collected and homogenized
in ice-cold lysis buffer (containing 20 mmol/L Tris, pH 7.5,
150 mmol/L NaCl, 1 mmol/L EDTA, 1 mmol/L EGTA, 1% Triton X-
100, 2.5 mmol/L Na-Pyrophosphate, 1 mmol/L b-glycerophosphate,
1 mmol/L Na3VO4, 1 g/mL leupeptin, and 1 mmol/L PMSF) and
then centrifuged at 16,000 rpm for 15 min. Protein samples were
electrophoresed on 10% Bis–Tris gels (Invitrogen) and transferred
onto polyvinylidene ﬂuoride membranes according to the manu-
facturer’s instructions (Invitrogen). Immunoblot analyses were
carried out with the following antibodies: anti-synaptophysin
(1:500, Abcam) and anti-b-actin (1:2000, Santa Cruz). Protein
expression level was quantiﬁed by densitometry (TotalLab, version
1.1, UK) for each blot. The density ratio for the bands was calcu-
lated. All data were expressed relative to the control as follows:
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2.6. Glutamate level and astrocyte expression of supernatant
Glutamate secretion was measured by a mouse anti-rat gluta-
mate enzyme-linked immunosorbent assay (Abcam). The superna-
tant solution from the aforementioned proliferation and
differentiation medium conditions was used as a sample 1, 3,
and 7 days after co-culture. The optical density was measured at
450 nm on a standard micro-plate reader (BioRad). Three indepen-
dent experiments were conducted.
3. Statistical analysis
Data were analyzed using Graph Pad Prism version 4.0. Values
are presented as the mean ± SD. Student’s t-test or Bonferroni cor-
rection was performed for statistical evaluation. A probability va-
lue of P < 0.05 was considered statistically signiﬁcant.
4. Results
4.1. Reduced efﬁcacy of shRNAs
shRNAs delivered into astrocytes by lentiviral vectors were used
to functionally silence GLT-1 expression, as conﬁrmed by real-time
PCR and Western blot analyses. Real-time PCR analysis indicated
that the shRNA delivered by lentiviral vectors functionally reduced
astrocyte GLT-1 expression to 35.5% of the control levels (Table 2).
Immunoblot analysis indicated that the protein level of GLT-1 de-Fig. 2. Effect of GLT-1 on the proliferation of NSCs upregulated by astrocytes. (A) Effe
prepared from ordinal SD rat embryo brains. GLT-1 expression level was downregulate
astrocytes. Bar represents 100 lm. (B) Effect of GLT-1 interference astrocytes on the cell
signiﬁcant differences between NSCs coculture with control vector infected astrocytes
indicated (NP < 0.001). (C) Effect of GLT-1 interference astrocytes on the number of neurp
with control vector infected astrocytes (Coculture) and NSCs only (Con), as determined by
astrocytes on the number of neurpheres (7-day co-culture). Statistically signiﬁcant diffe
and NSCs only (Con), as determined by the Bonferroni correction, are indicated (NP < 0.0creased by 71.5% when astrocytes were infected with GLT-1 shRNA
virus (Fig. 1).
4.2. Effect of GLT-1 on the proliferation of NSCs upregulated by
astrocytes
Astrocytes stimulated NSC proliferation after 3 and 7 days of co-
culture (149.0% ± 3.7% and 167.3% ± 4.0% vs. 100%, n = 3, all
P < 0.001), respectively. Cell growth exhibited no signiﬁcant de-
crease after NSCs were co-incubated with GLT-1-RNA-silenced
astrocytes (145.3% ± 2.5% vs. 149.0% ± 3.7%, 162.8% ± 3.5% vs.
167.3% ± 4.0%, n = 3, all P > 0.05; Figs. 2A and B). Morphologically,
the astrocytes showed increased self-renewal capacity, proliferat-
ing (12 ± 2/500 vs. 6 ± 1/500, 19 ± 2/500 vs. 8 ± 1/500) after 3 and
7 days in vitro (n = 3, all P < 0.001). The number of spheres exhib-
ited no signiﬁcant decrease after incubating GLT1-silenced
astrocytes with NSCs compared with those observed with NSCs
co-cultured with astrocytes (11 ± 2/500 vs. 12 ± 2/500, 18 ± 1/500
vs. 19 ± 2/500, n = 3, all P > 0.05; Fig. 2C and D).
4.3. Effect of GLT-1 on the differentiation of NSCs and synaptophysin
level upregulated by astrocytes
Resultant cultures were analyzed for neuronal and astrocytic
numbers by immunohistochemical staining with MAP-2 Ab/BrdU
Ab and GFAP Ab/BrdU Ab (Figs. 3A and 4A). As shown in Figs. 3B
and 4B, immunocytochemistry analysis revealed that astrocytes
signiﬁcantly increased the percentage of the numbers of MAP2
and BrdU-immunoreactive cells with neuronal morphology
(22.3% ± 1.2% vs. 15.7% ± 0.6%, n = 3, P < 0.001) and decreased thect of GLT-1 interference astrocytes on morphological changes of NSCs. NSCs were
d by loss-of-function approaches using RNA interference lentiviral gene transfer in
growth rate of NSCs (open circle, 3-day; closed circle, 7-day co-culture). Statistically
(Coculture) and NSCs only (Con), as determined by the Bonferroni correction, are
heres (3-day co-culture). Statistically signiﬁcant differences between NSCs coculture
the Bonferroni correction, are indicated (NP < 0.001). (D) Effect of GLT-1 interference
rences between NSCs coculture with control vector infected astrocytes (Coculture)
01).
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cells with astrocytic morphology (57.7% ± 2.1% vs. 69.7% ± 1.5%,
n = 3, P < 0.001). However, all these values were reversed after
GLT-1-silenced astrocytes were co-cultured with NSCs
(16.7% ± 0.6% vs. 22.3% ± 1.2%, 70.7% ± 2.5% vs. 57.7% ± 2.1%, n = 3,
all P < 0.01). The decreased number of new neurons signiﬁcantlyFig. 3. GLT-1 mediated astrocytes-upregulated the neuronal differentiation of NSCs. (
neurosphere immunostained with anti-BrdU Ab (Left, red) and anti-MAP2 Ab (Centre, g
(Right). The experiment was repeated thrice, and similar results were obtained each time
1 expression level was downregulated by loss-of-function approaches using RNA interfer
on the neuronal differentiation of NSCs (7-day co-culture). Statistically signiﬁcant differe
(Coculture vs. Con), as determined by the Bonferroni correction, are indicated (NP <
interference astrocytes and NSCs coculture with control vector infected astrocytes (GLT
(wP < 0.01). (For interpretation of the references to colour in this ﬁgure legend, the readincreased glial differentiation. Immunocytochemistry and immu-
noblot analysis revealed that GLT-1 siRNA downregulated the
astrocyte-induced elevation of the mean percentage of synapto-
physin-expressing neurons (22.3% ± 2.5% vs. 39.7% ± 3.2%, n = 3,
P < 0.01) (Fig. 5A and B) and synaptophysin protein expression
(Fig. 5C) after co-culturing with NSCs.A) Confocal microscopy of representative double-stained images of differentiated
reen). BrdU and MAP2 labelling are shown in both isolated and overlapping cases
. Bar represents 25 lm. NSCs were prepared from ordinal SD rat embryo brains. GLT-
ence lentiviral gene transfer in astrocytes. (B) Effect of GLT-1 interference astrocytes
nces between NSCs coculture with control vector infected astrocytes and NSCs only
0.001). Statistically signiﬁcant differences between NSCs coculture with GLT-1
-1 siRNA vs. Coculture), as determined by the Bonferroni correction, are indicated
er is referred to the web version of this article.)
Fig. 4. GLT-1 mediated astrocytes-downregulated the glial differentiation of NSCs. (A) Confocal microscopy of representative double-stained images of differentiated
neurosphere immunostained with anti-BrdU Ab (Left, red) and anti-GFAP Ab (Centre, green). BrdU and GFAP labelling are shown in both isolated and overlapping cases
(Right). The experiment was repeated thrice, and similar results were obtained each time. Bar represents 50 lm. NSCs were prepared from ordinal SD rat embryo brains. GLT-
1 expression level was downregulated by loss-of-function approaches using RNA interference lentiviral gene transfer in astrocytes. (B) Effect of GLT-1 interference astrocytes
on the glial differentiation of NSCs (7-day co-culture). Statistically signiﬁcant differences between NSCs coculture with control vector infected astrocytes and NSCs only
(Coculture vs. Con), as determined by the Bonferroni correction, are indicated (NP < 0.001). Statistically signiﬁcant differences between NSCs coculture with GLT-1
interference astrocytes and NSCs coculture with control vector infected astrocytes (GLT-1 siRNA vs. Coculture), as determined by the Bonferroni correction, are indicated
(wP < 0.01). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Y. Guo et al. / Neurochemistry International 63 (2013) 498–506 5034.4. Content of glutamate in the supernatant and astrocytes under
different medium conditions
Throughout a week of using the medium for proliferation
study, the supernatant concentration of glutamate signiﬁcantlyincreased when NSCs were co-cultured with both astrocytes
and GLT-1 siRNA astrocytes. The supernatant level of gluta-
mate increased by approximately by 30% after co-culturing NSCs
with GLT-1 siRNA astrocytes for 3 and 7 days, and a statisti-
cally signiﬁcant difference was observed (9.2 ± 1.0 nmol/L vs.
Fig. 5. GLT-1 mediated astrocytes-upregulated the synapse-related gene synaptophysin. (A) Confocal microscopy of representative three-stained images of new neurons
immunostained with anti-MAP2 Ab (Red), anti- synaptophysin Ab (Green) and DAPI (Blue) when co-cultured with astrocytes on differentiation condition. Area inside white
box is enlarged below. Labelling were shown in both isolated and overlapping cases. Bar represents 50 lm and 200 lm (partial larger image). (B) Synaptophysin positive new
neurons when NSCs co-cultured with GLT1 interference astrocytes. (C) Western blotting analysis using anti-synaptophysin was performed to investigate protein levels of
synaptophysin Representative photographs from three to four independent experiments are shown. NSCs were prepared from ordinal SD rat embryo brains. GLT-1 expression
level was downregulated by loss-of-function approaches using RNA interference lentiviral gene transfer in astrocytes. Statistically signiﬁcant differences between NSCs
coculture with control vector infected astrocytes and NSCs only (Coculture vs. Con) are indicated (NP < 0.001), or between NSCs coculture with GLT-1 interference astrocytes
and NSCs coculture with control vector infected astrocytes coculture with NSCs (GLT-1 siRNA vs. Coculture) are indicated (wP < 0.001). (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Table 3
The content of glutamate in the supernatant of different media conditions.
1 day 3 day 7 day
Proliferation media
Control (NSCs only) 4.2 ± 0.6 5.2 ± 0.6 5.5 ± 0.8
NSCs cocultured with astrocytes 6.4 ± 0.7# 7.1 ± 0.6# 8.0 ± 0.8#
NSCs cocultured with Glut1 siRNA
astrocytes
7.4 ± 0.7 9.2 ± 1.0N 10.4 ± 0.9N
Differentiation media
Control (NSCs only) 4.6 ± 0.6 7.6 ± 1.0 10.6 ± 0.8
NSCs cocultured with astrocytes 5.7 ± 0.5 8.6 ± 0.9 12.8 ± 1.3
NSCs cocultured with Glut1 siRNA
astrocytes
6.5 ± 0.9 20.4 ± 1.7NN 30.7 ± 3.5NN
Units = nmol/L for all data in the table. N = 10 for each group.
# Indicates P < 0.05 NSCs cocultured with astrocytes compared to Control.
N Indicates P < 0.05.
NN Indicates P < 0.001 NSCs cocultured with Glut1 siRNA astrocytes compared to
NSCs cocultured with astrocytes.
Y. Guo et al. / Neurochemistry International 63 (2013) 498–506 5057.1 ± 0.6 nmol/L; 10.4 ± 0.9 nmol/L vs. 8.0 ± 0.8 nmol/L, n = 10, all
P < 0.05).
In the differentiation culture medium, the astrocytes slightly in-
creased the supernatant concentration of glutamate after co-cul-
turing with NSCs, but the difference was not signiﬁcant. The level
further increased to 6.5 ± 0.9, 20.4 ± 1.7, and 30.7 ± 3.5 nmol/L after
co-culturing NSCs with GLT-1 siRNA astrocytes. A statistically sig-
niﬁcant difference was found 3 and 7 days after culture (n = 10, all
P < 0.001), and GLT-1 siRNA astrocytes increased the supernatant
level of glutamate by approximately 150% after co-culturing with
NSCs at these two timepoints (Table 3).5. Discussion
Studies have indicated that dysfunctional glutamate reuptake
promotes neuronal death after brain injury. Although the regula-
tion of NSCs has been extensively studied, studies on the prolifer-
ation and differentiation of NSCs after injury are limited. Reactive
astrogliosis is a signiﬁcant process that responds to almost all inju-
ries and pathologies of the CNS. In these cases, reactive astrocytes
are present and secrete numerous molecules and growth factors. In
this work, we determined whether GLT-1 mediated synaptic func-
tion and the astrocyte regulation of the cell fate of NSCs by affect-
ing glutamate-reuptake function. siRNAs targeting GLT-1 were
delivered to astrocytes by lentiviral vectors. Notably, primary
astrocytes can dramatically affect the cell fate of NSCs by stimulat-
ing neuronal lineage selection but potentially inhibit glial lineage
cells through GLT-1. The cell growth of NSCs was not affected by
astrocytes. Furthermore, co-cultures of NSCs and primary astro-
cytes increased the synaptic function of new NSC-derived neurons
through GLT-1. Glutamate was detected in the supernatants of co-
culture and astrocytes under different medium conditions, which
can be attributed to the slower rate of clearance of the released
glutamate. Such dysfunctional glutamate reuptake may be a major
consequence of GLT-1 functional silence in astrocytes.
The results of this study supported the previous ﬁnding that
hippocampal astrocytes promote the neuronal lineage selection
of NSCs (Faijerson et al., 2006). However, inhibition of NSC-derived
astrocytic differentiation was observed after NSCs were co-cul-
tured with hippocampal astrocytes. This discrepancy may have re-
sulted from the lesioned astrocytes and the conditioned medium
from lesioned astrocytes used in the previous study, which report-
edly promotes astrocytic differentiation. In the current prolifera-
tion study, astrocytes did not affect the proliferation of NSCs
after co-culturing with NSCs. These results suggested that the ef-
fects on astrocytic differentiation primarily resulted from the in-
creased induction of fate commitment to the neuronal lineagefrom NSCs. The pronounced effect on astrocytic differentiation ob-
served in NSC co-cultured astrocytes indicated that this effect was
primarily mediated by substances secreted from the astrocytes.
Whether this effect also resulted from the basal reactive state
inherent in primary astrocytes and the exact mechanism linking
it to astrogliosis after brain injury are unclear. Additionally, syn-
apses and synaptic integrity allow neurons to form circuits within
the CNS. To characterize changes in the function of synapses, we
measured the levels of synaptophysin, a glycoprotein component
of synaptic vesicles and a synaptic marker. Synaptophysin report-
edly regulates activity-dependent synapse formation (Tarsa and
Goda, 2002). We observed that the presence of astrocytes pro-
foundly increased the synaptophysin levels, and this effect was
blocked after siRNA-targeting GLT-1 was delivered to astrocytes
by lentiviral vectors. However, synaptophysin staining was distrib-
uted mainly in cell bodies rather than in the synaptic terminals,
there are no more synapses to export it into, these ﬁndings may
be an indication that GLT-1 in astrocytes was involved in the levels
of synaptophysin but not change the synapse numbers.
Glutamate is critical to normal brain function and brain devel-
opment. Perturbations of glutamate neurotransmission have se-
vere consequences. Continuous glutamate release leads to a
spreading of the process (Choi, 1992) termed excitotoxicity. Gluta-
mate excitotoxicity has been implicated in a number of brain dis-
orders, including epilepsy, amyotropic lateral sclerosis,
Huntington’s disease, Alzheimer’s disease, ischemia, and trauma
(Eid et al., 2004; Fujikawa, 2005; Hynd et al., 2004; Rego and de Al-
meida, 2005; Rothstein, 1996; Tannenberg et al., 2004). The capac-
ity of glutamate to be highly toxic yet necessary for
neurotransmission sets a ﬁne balance between plasticity and
pathology.
Previous studies have revealed that the glutamate–glutamine
cycle is crucial to synaptic plasticity associated with cognitive pro-
cesses. Thus, this cycle may be involved in the regulation of inhib-
itory synaptic strength, which can inﬂuence circuit excitability
under normal and pathological conditions (Eid et al., 2004; Rae
et al., 2003). Astrocytes are essential to glutamatergic transmis-
sion, being key elements for the synthesis of glutamate and for
the glutamate–glutamine cycle. Meanwhile, one of the important
sources of glutamate is the astrocytic glutamate–glutamine cycle,
by which glutamate is uptaken by astrocytes through the astro-
cyte-speciﬁc GLT-1 and converted into glutamine by glutamine
synthetase (Arriza et al., 1994; Pines et al., 1992). Glutamate must
be rapidly and efﬁciently cleared from the synaptic cleft to reduce
background signal trafﬁc and prevent over-stimulation of recep-
tors. This action is attributed to GLT-1, which is presumed by
immunohistochemical and in situ studies to be astrocytic proteins.
This phenomenon is responsible for removing extracellular gluta-
mate in the CNS and is critical to the prevention of excitotoxicity
(Choi et al., 1987) and modulation of synaptic transmission (Huang
and Bergles, 2004).
This study provided a plausible mechanism underlying the
effect of astrocytes on the cell fate of NSCs following brain
injury. Our previous study has shown that chronic unpredicted
mild stress alters ischemia-induced neurogenic fate by increasing
the differentiation of NSCs to glial lineage cells. We observed that
the stressors affecting the ischemia-related neurogenesis of the
hippocampus are probably mediated by GLT-1. Both the increased
release (caused by ischemia) and decreased reuptake caused by
GLT-1 dysfunction may lead to increased duration of glutamate ac-
tion in the synaptic cleft, thereby exacerbating ischemic neuronal
damage and impairing neurogenesis. Reactive astrogliosis is re-
garded as dysfunctional glutamate reuptake because of the pres-
ence of GLT-1 after brain injury. Astrocytes seem to rapidly and
efﬁciently clear glutamate from the synaptic cleft, thereby inhibit-
ing excitotoxicity.
506 Y. Guo et al. / Neurochemistry International 63 (2013) 498–506Interpretation of the data in this study has certain limitations.
First, multipotent NSCs can differentiate into neurons, astrocytes,
and oligodendrocytes under certain culture conditions (Emsley
et al., 2005). Thus, under the differentiating medium condition,
the effects of oligodendrocytes cannot be excluded. Astrocytes in
culture are generally believed to express little or no GLT-1, and
astrocyte activity is known to be mainly mediated by GLAST. At
present, shRNAs delivered by lentiviral vectors do not fully silence
GLT-1 expression in astrocytes. Further in vivo studies may be re-
quired to investigate the effects of astrocytes on neurogenesis
and to provide more details on the mechanism involved. Despite
these limitations, the ﬁndings raise the possibility that primary
astrocytes can dramatically affect the cell fate of NSCs by stimulat-
ing neuronal lineage selection, inhibiting glial lineage cells, and
potentially promoting synaptic function through GLT-1. Reactive
astrogliosis is regarded as the cellular response to brain injury,
such as stress after ischemia. Further investigations are required
to determine the precise mechanism.
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